10
Thursday, April 5, 2001
JULIAN'S
From Page 3
visit Julian’s when they return to their
alma mater. “Some of the alumni have
come in and said, ’lt feels the same
way, but you changed this or that,’*
she said. “I will tell them that my dad
didn’t get to stay in business for him
self for 50 years by being the exact
same thing he was the day he opened.”
Decades after opening, Julian-Fox said
the store continues to uphold the tradi
tions and core beliefs on which it was
MW filTffl fUI fWil liMl
Eastgate Shopping Center
Dansko
Birkenstock Comfortable Soles
SPECIALTY STORE
s'* C - hapel Hl " Raleigh
1 (w.so.L,*™,
| J 933-1300 Open 7 days 8289567
Don't miss out on
C' A IM A this chance to recognize
L. 11 > t\ the individuals who
2@*®l h “ur„ i r m
OFFICIALLY RECOGNIZED STUDENT ORGANIZATIONS.'
Nominations for
Outstanding Senior/Favorite Faculty
AWAFtDS
are due by 5 p.m., Friday. April 6
to the George Watts Hill Alumni Center.
Nomination forms can be picked up at The Union desk or The George Watts Hill Alumni Center
BpTc
I -f 4 1 '
VWP" * V
/tim CATERING
breakfast • luncH ■ dinner
since 19 88
fjßßa 7 day delivery to UNC W
• Over age 35 and smoke 15 or more cigarettes
per day
Tell your health care provider if you have ever had
any of these conditions. Your health care provider
can recommend a safer method of birth control
ABE THERE OTHER THINGS TO CON
SIDER BEFORE TAKING LUNELLE™
MONTHLY CONTRACEPTIVE INJECTION?
For the majority of women, hormonal contracep
tives can be taken safely But there are some
women who are at high risk of developing certain
serious diseases that can be life-threatening or
may cause temporary or permanent disability. Tell
your health care provider if you have:
• Breast nodules, fibrocystic disease of the
breast, an abnormal breast x-ray or mammo
gram, strong family history of breast cancer
• Diabetes
• Elevated cholesterol or triglycerides
• High blood pressure
• Migraine or other headaches or epilepsy
• Mental depression
• Gallbladder, heart or kidney disease
• History of scanty or irregular menstrual periods
• Smoke especially it 35 years or older
Women with any of these conditions should be
checked often by their health care provider if they
choose to use LUNELLF" Monthly Contraceptive
Injection.
Also, be sure to inform your doctor or health care
provider if you smoke or are on any medications
WHATJVPE THE RISKS ASSOCIATED WITH
TMINS HORMONAL CONTRACEPTIVES?
1. Risk ot developing blood clots, heart
attacks, and strokes
Blood clots and blockage ot blood vessels are the
most serious side effects ol taking hormonal con
traceptives In particular, blood clots can occur in
the legs and can travel to the lungs and can cause
sudden blocking ol the vessel carrying blood to
the lungs. Rarely, clots occur in the blood vessels
of the eye and may cause blindness, double
vision, or impaired vision
If you take hormonal contraceptives such as
LUNELLF" Monthly Contraceptive Injection and
need elective surgery, need to stay in bed lor a
prolonged illness, or have recently had a baby,
you may be at risk of developing blood clots. You
should consult your doctor about stopping hor
monal contraceptives three to four weeks before
surgery and not taking hormonal contraceptives
tor two weeks after surgery or during bed rest. You
should also not take hormonal contraceptives
soon after delivery ot a baby It is advisable to wait
for at least four weeks after delivery before using
hormonal contraceptives such as LUNELLF"
Monthly Contraceptive Injection. (See also the
section on Breast Feeding in WHAT PRECAU
TIONS SHOULD BE FOLLOWED DURING THE
USE OF LUNELLE MONTHLY CONTRACEPTIVE
INJECTION?)
Hormonal contraceptives may also increase the
tendency to develop strokes (stoppage or rupture
of blood vessels in the brain) and angina pedoris
and heart attacks (blockage ot blood vessels in the
heart). Any of these conditions can cause death or
disability.
Smoking greatly increases the possibility of devel
oping blood clots or suffering heart attacks and
strokes Furthermore, smoking and the use erf hor
monal contraceptives greatly increase the chances
ot developing and dying of heart disease, particu
larly it you are over 35 years of age
2. Gallbladder disease
Hormonal contraceptive users probably have a
greater risk than non-users of having gallbladder
disease
3. Liver tumors
In rare cases, hormonal contraceptives can cause
benign but dangerous liver t>jmors These benign
LUNELLE™ Monthly Contraceptive Injection
medroxyprogesterone acetate and estradiol
cypionate injectable suspension
LUNELLE 1- Monthly Contraceptive Injection
(like all hormonal contraceptives) is
intended to prevent pregnancy.
It does not protect against HIV infection
(AIDS) and other sexually transmitted
diseases.
This summary contains important information
about LUNELLE'" Monthly Contraceptive
Injection It is not meant to take the place of dis
cussions with your doctor and it cannot replace
your doctor’s advice. Only your doctor can assess
the benefits and risks to decide if LUNELLE™
Monthly Contraceptive Injection is right for you.
Talk to your doctor or pharmacist, or other pre
scribing healthcare professional, if you do not
understand any of Ihis information or if you wan!
to know more about LUNELLF" Monthly
Contraceptive Injection,
WHAT JS LUNELLE™ MONTHLY CONTRA
CEPTIVE INJECTION?
LUNELLE™ Monthly Contraceptive Injection is a
type of hormonal birth control that is given as an
injection (a shot) in your arm thigh, or buttock
once a month to prevent pregnancy It contains
hormones which have effects similar to the natural
hormones, estrogen and progesterone, produced
in your body Similar combinations ol hormones
are found in some oral contraceptives also known
as “birth control pills” or “the pill." When you
receive your injections once a month as pre
scribed LUNELLF" Monthly Contraceptive
Injection is as effective as birth control pills When
given according to the prescribed schedule,
LUNELLE " Monthly Contraceptive Injection is
effective in preventing pregnancy during the cycle
in which it is given Clinical studies have shown
that when women receive LUNELLF" Monthly
Contraceptive Injection according to the recom
mended schedule, the failure rate of this method
of birth control is less than 1 % per year
WHO SHOULD NOT TAKE LUNELLE™
MONTHLY QONTBACEPTIVE INJECTION?
Cigarette smoking increases the risk of
serious cardiovascular side effects from
hormonal contraceptive use. This risk
increases with age and with heavy smok
ing (15 or more cigarettes per day) and is
quite marked in women over 35 years ot
age. Women who use hormonal contra
ceptives are strongly advised not to smoke.
Some women should not use hormonal contra
ceptives For example, you should not take
LUNELLF" Monthly Contraceptive Injection if you
are pregnant or think you may be pregnant. You
should also not use LUNELLF" Monthly
Contraceptive Injection it you have any of the fol
lowing conditions
• A history of heart attack or stroke
• Blood clots in the legs (thrombophlebitis),
lungs (pulmonary embolism), or eyes
• A history ol blood clots in the deep veins of
your legs
• Chest pain (angina pectoris)
• Known or suspected breast cancer or cancer ot
the lining of the uterus, cervix or vagina
• Unexplained vaginal bleeding (until a diag
nosis is reached by your doctor)
• Yellowing of the whites of the eyes or of the
skin (jaundice) during pregnancy or during
previous use of the pill or other hormonal
contraceptives
• Liver tumor (benign or cancerous)
• Known or suspected pregnancy
• Allergy to any ol the ingredients contained in
LUhCLLF" Monthly Contraceptive Injection
founded. “Our almost 60-year history
has been about traditional with a twist,”
she said. “It’s great style, good fit, a lot of
flexibility. It makes customers look good,
which translates into feel good.”
This tradition also includes a close
relationship with the University.
“Our connections with the University
ran very deep, all the way from my
brother inventing the basketball uniform
to having a need-based scholarship in
our mom and dad’s honor,” Julian-Fox
said. “We’re proud of everything we’re
able to do with this business.”
The store also has employed many
liva tumors can rupture ant) cause latal internal
bleeding. In addition, a possible but not definite
association has been found with hormonal contra
ceptives and liver cancers in two studies, in which
a few women who developed these very rare can
cers were found to have used hormonal contra
ceptives for long periods. However, liver cancers
are extremely rare. The chance of developing liver
cancer from using hormonal contraceptives is thus
even rarer.
4. Cancer of the reproductive organs and
breasts
There is, at present, no confirmed evidence that
oral hormonal contraceptives increase the risk of
cancer of the reproductive organs in human stud
ies. Studies to date of women taking the pill have
reported conflicting findings on whether pill use
increases the risk ol developing cancer of the
breast Most of the studies on breast cancer and
pill use have found no overall increase in the risk
of developing breast cancer, although some stud
ies have reported an increased risk of developing
breast cancer in certain groups of women.
Some studies have found an increase in the inci
dence of cancer ol the cervix in women who use
oral hormonal contraceptives. However, this find
ing may be related to factors other than the use ot
oral hormonal contraceptives
Studies have found that women who used
injectable hormonal contraceptives (Depo-Provera
Contraceptive Injection) had no increased overall
risk of developing cancer of the breast, ovary,
uterus, or cervix. However, women under 35 years
ot age whose first exposure to Depo-Provera
Contraceptive Injection was within the previous 4
to 5 years may have a slightly increased risk of
developing breast cancer similar to that seen with
oral contraceptives
Women who use hormonal contraceptives and
have a strong family history of breast cancer or
who have breast nodules or abnormal mammo- .
gram should be closely followed by their doctors.
5. Changes in bone mineral density
Use of injectable hormonal contraceptives con
taining the progesterone-type hormone found in
LUNELLF" Monthly Contraceptive Injection may
be associated with a decrease in the amount of
mineral stored in your bones. This could increase
your risk of developing bone fractures. The rate of
bone mineral loss is greatest in the early years of
use of this type of contraceptive, but after that, it
begins to resemble the normal rate of age-related
bone mineral loss
6. Allergic reactions
Severe allergic reactions have been reported in
some women using injectable hormonal contra
ceptives containing the progesterone-type hor
mone found in LUNELLF" Monthly Contraceptive
Injection. Allergic reactions occurring in women
using LUNEU£™ Monthly Contraceptive Injection
have been mainly skin reactions, and not respira
tory in nature. Serious allergic reactions require
emergency medical treatment.
ESTIMATED BISK OF OEATH FROM A BIRTH
CQHTBOL METHOD OH PBEGWAWCY
All mettiods ol birth control and pregnancy are
associated with a risk ol developing certain dis
eases that may lead to disability or death An esti
mate ol Ihe number ol deaths associated with dit
letent methods ol birth control and pregnancy has
been calculated.
The risk ol death tram any birth control method is
less than the risk ot childbirth, except lot oral hor
monal contraceptive users cm Ihe age ot 35 who
smoke and oral hormonal contraceptive usets
over the age ol 40 even it they do not smoke. For
women aged 15 to 39. the risk ol death was high
est with pregnancy (7-26 deaths per 100.000
women, depending on age). Among orelhormon
al contraceptive usets who do not smoke, Ihe risk
From Page Three
UNC students. Julian-Fox said they
provide a creative edge to the business
and form part of an extended family.
“Working at Julian’s was a wonderful
experience,” said former employee
Eliza Warren, a senior journalism major.
“They’re your employers, and they’re
also your friends. I transferred here, and
Julian’s really took me under their wing
and helped me meet people.”
Lately, the store has been involved
with the University in other ways.
Tonight, Julian’s will be among the
designers showcasing everything from
beachwear to formaiwear at a fashion
show at 7 p.m. in the Great Hall.
Proceeds from the show, sponsored by
the Kenan-Flagler Business School, will
go to the Durham Scholars, an after
school program for minorities at local
elementary schools. Tickets are $6.
In the fall, Julian’s also kicked off its
Men of Style advertising campaign.
After placing advertisements for volun
teering models in The Daily Tar Heel,
the store choose 14 UNC men to
appear in its fall campaign. “The whole
thing was about applauding our college
fellows and their sense of style,” Julian-
Fox said. “We just had a wonderful time
with that, and I think they would say
they had a good time, too.”
Following the success of its initial
Men of Style campaign, the store plans
to host another one this fall.
Even with the evolving times,
Julian-Fox said the store’s green
canopy will complement the street
facade for many years to come.
“We grew up by hearing people say
ing ‘l’ll meet you at Julian’s after the
game,’” Julian-Fox said. “We figure if
we continue to hear that, then we’ll
continue to work to be here.
“This is our town and our street and
our university, and you can’t take
away any segment of that. It just
wouldn’t be the same.”
The Features Editor can be reached
at features@unc.edu.
cut and savell
_ Hey Ca*oua*
( i'Mm you can earn sss and contribute
to the future of medicine.
Are You:
•A healthy individual
• Willing to participate in medically supervised research studies.
S3*Yes.. .then you may be eligible to participate.
You have to meet certain criteria to qualify for a study,
including our free medical exam and screening tests.
,Fpr information about these studies, please call
PPD DEVELOPMENT
1-800-PPD-CRU2 • (1-800-773-2782)
E-mail: Rtp-Cllnlo@rtp.ppdi.com • Visit our web site for more study info: http://www.ppd.citysearoh.oom
Listen for our ads on MIXIOI and WBBB
CURRENT STUDY OPPORTUNITIES
Study Compensation Requirements
#253 Up to SIOOO Healthy, Nonsmoking Males. Ages 18-45.
TIMELINE: Call for Dates and Times
#256 Up to S7OO Healthy, Nonsmoking Males and Females (non-pregnant). Ages 1845.
TIMELINE: CALL FOR DATES.
_ DEVELOPMENT Conducting clinical studies since 1983
of death is always lower than that associated with
pregnancy for any age group, although over the
age of 40, the risk increases to 32 deaths per
100,000 women, compared to 28 associated with
pregnancy at that age. However, for oral hormonal
contraceptive users who smoke and are over the
age of 35, the estimated number of deaths
exceeds those for other methods of birth control.
It a woman is over the age of 40 and smokes,
her estimated risk ot death is four times higher
(117/100.000 women) than the estimated risk
associated with pregnancy (28/100,000 women)
in that age group.
An Advisory Committee of the FDA discussed this
issue in 1989 and recommended that the benefits
of oral contraceptive use by healthy, non-smoking
women over 40 years of age may outweigh the
possible risks. However, women ot all ages are
cautioned to use the lowest dose oral contracep
tive that Is effective, and are strongly advised not
to smoke.
WHAT SYMPTOMS MAY SIGNAL PROB
LEMS WHILE USING IUN£IIE!!IMQNTH
LY CONTRACEPTIVE INJECTION?
Call your doctor immediately if any of these
adverse effects occur while you are taking
LUNELLE™ Monthly Contractive Injection
• Sharp chest pain, coughing ol blood, or sudden
shortness of breath (indicating a possible clot
in the lung)
• Pain in the calf (indicating a possible dot in the leg)
• Crushing chest pain or heaviness in the chest
(indicating a possible heart attack)
• Sudden severe headache or vomiting, dizziness
or tainting, disturbances of vision or speech,
weakness, or numbness in an arm or leg
(indicating a possible stroke)
• Sudden partial or complete loss of vision
(indicating a possible clot in the eye)
• Breast lumps (indicating possible breast cancer
or fibrocystic disease of the breast; ask your
doctor or health care provider to show you how
to examine your breasts)
• Severe pain or tenderness in the abdominal
area (indicating a possibly ruptured liver tumor,
ovarian cyst, or pregnancy outside the uterus)
• Difficulty in sleeping, weakness, lack of energy,
fatigue, or change in mood (possibly indicating
severe depression)
• Jaundice or a yellowing ot the skin or eyeballs,
accompanied frequently by fever, fatigue, loss
of appetite, dark-colored urine, or light-colored
bOAel movements (indicating possible liver
problems)
• PersisJertpain. pus, or bleeding althe injection site
• Unusually heavy vaginal bleeding
WMTAfIE IMPOSSIBLE SIPEEPFECTS
OF LUNEU.E™ MONTHLY CONTRACT
1. Vaginal bleeding
Most women using LUNELLF" Monthly
Contraceptive Injection experience alteration of
menstrual bleeding Bleeding patterns may vary
from a single monthly bleed to no bleeding at ail
or slight staining between menstrual periods to
frequent, prolonged, and/or unpredictable bleed
ing. In any given injection interval, approximately
50% of women using LUNELLF" Monthly
Contraceptive injection experience withdrawal
bleeding that begins 20-25 days after the injec
tion Withdrawal bleeding lasts more than 7 days
in 42% of women during the first month of use
and in 29% of women at the end of one year of
use. In any given injection interval, approximately
15% of women may have no bleeding at all and
10% may experience bleeding or spotting at vari
ous times in the cycle Irregular bleeding often
occurs during the first few months of LUNELLF"
Monthly Contraceptive Injection use and may per
sist with continued use in up to one third ot
women. Your menstrual blood flow may be heev
HHr JiBBC -
W HI
;.VrJjglppppi . S? -
v
'HB- ’ ”
DTH/SEFTONIPOCK
Senior Ryan Dahl leads other members of the men's club rugby team in a passing drill Wednesday afternoon.
The team is getting ready for a trip to compete in the national rugby Sweet 16.
RUGBY
From Page 3
there are benefits to being a club team.
“You’re not required to do anything,
so the people who come out to practice
are there because that’s how they want
to spend the next two or three hours of
their day,” he said.
And Powell said he is confident the
players will find a way to compete because
ier or lighter, and there may be no bleeding, fewer
days of bleeding, or more days ot bleeding than
what you have previously experienced. Such
bleeding usually does not indicate any serious
problems. If an altered bleeding pattern persists or
the bleeding is severe, discuss it with your health
care provider. There is also a small risk that
(painful) cramps may be associated with bleeding.
2. Weight change
Weight gain is a common side effect in women
using LUNELLE™ Monthly Contraceptive
Injection. The average expected weight gain is 4
pounds in the first year of use. Some women gain
more than 10 to 20 pounds in the first year
Women have gained as much as 49 pounds or
lost as much as 48 pounds in one year of use
Clinical trials showed wide variability in individual
weight change with an increasing percentage of
LUNELLE™ Monthly Contraceptive Injection users
experiencing weight change in excess of 10 and
20 pounds with continued treatment
3. Contact lenses
If you wear contact lenses and notice a change in
vision or an inability to wear your lenses, contact
your doctor or health care provider.
4. Fluid retention
Hormonal contraceptives may cause edema (fluid
retention) with swelling of the fingers or ankles and
may raise your blood pressure. It you experience
fluid retention, contact your doctor or health care
provider.
5. Other side effects
Other side effects may include breast pain or ten
derness, acne, change in appetite, nausea, headache,
nervousness, depression, mood changes, changes
in sexual desire, dizziness, loss of scalp hair, rash,
and vaginal infections. If any of these side effects
bother you, call your health care provider.
MONTHLY CQNTRACEmVEINJEaiQN^
1. Missed periods and use of hormonal con
traceptives before or during early pregnancy
You may not menstruate regularly after you
receive an injection of LUNELLE™ Monthly
Contraceptive Injection. If you have received your
injections regularly and miss one menstrual peri
od, be sure to inform your health care provider.
The risk of unexpected pregnancy for women
receiving injectable contraceptives as scheduled is
very low. If you have not received your injections
as scheduled and missed a menstrual period, or if
you missed two consecutive menstrual periods,
you may be pregnant Check with your health care
provider immediately to determine whether you
are pregnant Do not continue the injections until
you are sure you are not pregnant, but use another
method of contraception
There is no conclusive evidence that oral hormonal
contraceptive use is associated with an increase in
birth detects, when taken inadvertently during early
pregnancy Nevertheless, hormonal contraceptives
should not be used during pregnancy
With Depo-Provera Contraceptive Injection, there
have been reports of an increased risk of low birth
weight and neonatal infant death or other health
problems in infants conceived close to the time of
injection. However, these pregnancies are uncom
mon. Children exposed in the womb to one of the
hormones found in LUNELLE™ Monthly
Contraceptive Injection (MPA), and followed to
adolescence, showed no evidence of any adverse
effects on their health including their physical,
mental, sexual or social development
If you think you may have become pregnant white
using LUNELLE™ Monthly Contraceptive Injection,
see your health care provider as soon as possible
You should check with your health care provider
about risks to your unborn child from any medica
tion taken during pregnancy.
2. While breast feeding
If you are breast feeding, consult your health
care provider before starting hormonal contracep
tives, including LUNELLE™ Monthly
Contraceptive Injection. Some ot the drugs in hor
monal contraceptives are passed on to the child in
breast milk. A tew adverse effects on the child
have been reported, including yellowing of the
skin (jaundice) and breast enlargement In addi
tion, hormonal contraceptives may decrease the
amount and quality of your milk. To insure the
best quantity and quality of your breast milk, you
should wait until 6 weeks after childbirth before
K start using LUNELLE™ Monthly Contraceptive
. ction. If possible, do not use hormonal contra
ceptives while breast feeding.
Breast feeding provides only partial protection
from becoming pregnant and this partial protec
tion decreases significantly as you breast feed lor
longer periods ol time. You should use another
method of contraception while breast feeding and
consider starling hormonal contraceptives only
after you have weaned your child completely
3. Laboratory tests
If you are scheduled tor any laboratory tests, tell
your doctor you are taking a hormonal contracep
tive. Certain blood tests may be affected by hor
monal contraceptives.
4. Drug interactions
Certain drugs may interact with hormonal contra
ceptives to make them less effective in preventing
pregnancy or cause a change in bleeding patterns.
Such drugs include aminoglutethimide, rifampin,
drugs used tor epilepsy such as barbiturates (for
example, phenobarbital). carbamazepine. and
phenytoin (Dilantin is one brand of this drug),
phenylbutazone (Butazolidin is one brand), herbal
products containing St. John’s Wort (hypericum
perforatum), and possibly certain antibiotics. You
may need to use an additional contraception
method when you take drugs which can make
hormonal contraceptives less effective. Drug inter
action studies have not been conducted with
LUNELLE™ Monthly Contraceptive Injection.
5. Sexually transmitted diseases
This product (like ail hormonal contracep
tives) is intended to prevent pregnancy.
It does not protect against transmission ot
HIV (AIDS) and other sexually transmitted
diseases such as chlamydia, genital her
pes, genital warts, gonorrhea, hepatitis B,
and syphilis.
6. Weight change
LUNELLF" Monthly Contraceptive Injection may
cause weight gain of more than 10 pounds.
mm DO I GET MY IUNEIIE™LMQKTM
LY CONTRACEPTIVE INJECTION?
LUNELLE™ Monthly Contraceptive Injection can
only be effective if you receive your injections at
the proper times.
First Injection
• Within the first 5 days of the start ol your
normal menstrual period.
• If you are presently using another type of birth
control, your health care provider will decide
the best time for you to start LUNELLF"
Monthly Contraceptive Injection. This will help
make sure you have continued contraceptive
coverage
• If you have recently been pregnant or had a
baby, discuss with your health care provider the
best time lor you to start LUNELLE™ Monthly
Contraceptive Injection.
Next Injections
• LUNELLF" Monthly Contraceptive Injection
must be given monthly, every 28 to 30 days and
no later than 33 days after your last injection.
The time for your next injection is determined
by the number of days since your previous
injection, and not by the timing or amount of
they are all very committed to the team.
“They have determination and dedi
cation,” he said. “They are there basi
cally every night of the week, and they
fund themselves.”
Dahl said the members have sacri
ficed a lot to get where they are, includ
ing practicing three days a week for two
hours, conditioning two days a week for
at least one hour and then playing on
the weekends.
Recently, Powell said he has been able
your menstrual bleeding.
Even if you do not have any menstrual bleed
ing, you should still return once a month for
your injection of LUNELLE™ Monthly
Contraceptive Injection.
l • It is important that you receive each of your next
injections at the right time. If you cannot receive
your injection on time, contact your health care
provider to receive an earlier injection
What Happens if I Miss an injection or Wait
Longer than 33 Days Between Injections?
• You could become pregnant if you miss your
injection or wait longer than 33 days between
; injections. The more days you wait, the greater
the risk that you could become pregnant.
• Ask your health care provider to recommend
another type of birth control (such as condoms
or a spermicide) tor you to use.
• Talk with your health care provider to find out
when you should receive your next injection of
LUNELLE™ Monthly Contraceptive Injection.
• Your health care provider may do a test to make
sure you are not pregnant before giving you
your next injection of LUNELLE™ Monthly
Contraceptive Injection.
Pregnancy Due to Failure with LUNELLE™
Monthly Contraceptive Injection
The incidence of failure LUNELLE™ Monthly
Contraceptive Injection resulting in pregnancy is
less than 1 percent (i.e., one pregnancy per 100
women per year) if given every month as directed.
If you think that you may be pregnant, be sure to
call your health care provider.
What tf I Want to Become Pregnant?
You will need to stop your monthly injections of
LUf€LLF" Monthly Contraceptive Injection Most
women begin to produce eggs again (and could
become pregnant) about two to three months after
their last injection
There may be some delay in becoming pregnant
after you stop using hormonal contraceptives, inclu
ding LUNELLE™ Monthly Contraceptive Injection,
especially if you had irregular menstrual cycles
before you started using hormonal contraceptives.
There does not appear to be any increase in birth
detects in newborn babies when pregnancy occurs
soon after stopping hormonal contraceptives
Serious ill effects have not been reported following
ingestion of large doses of oral hormonal contraceprives
by young children. may cause nausea and
withdra/ral bleeding in females. In case of overdosage,
contact your health care pra/ider or pharmacist.
Keep this and all drugs out ol the reach ol children
QIBERINFQBMATIQN
Your health care provider will take a medical
and family history before prescribing hormonal
contraceptives. You should receive yearly physical
examinations by your health care provider Be sure
to inform your health care provider if there is a
family history ol any ot the conditions listed previ
ously in this leaflet Be sure to keep ail appoint
ments with your health care provider, because this
is a time to determine if there are early signs of
side effects of hormonal contraceptive use. If you
want more information about hormonal contracep
tives, ask your health care provider or pharmacist
for a more technical leaflet called the Prescribing
Information that you may wish to read.
Rxonly: .
Manufactured by?
Pharmacia & Upjohn Company
Kalamazoo, Ml 49001, USA
CB-2-S
[A Lunelle “
QJtjr Battg (Ear iifri
to see that hard work make a difference.
“Their skill level has improved dra
matically over the last couple months,”
he said.
Dahl said hi; thought those skills
would pay off ini the Sweet 16. “We’ve
made it to the round before this a couple
times, but this is the first time we’ve bro
ken through -but hopefully not the last”
The University Editor can be reached
at udesk@unc.edu.
DAP
From Page 3
is hidden in pant which can be
rolled up once outside the office.
Lakhany launched the Dap-Rugget
line with designer Cedric King. He
said most of their funding came from
family ties and friends of King.
Dap-Rugget clothes are sold
throughout the Northeast in various
stores, namely Lim’s, a 25-30 store
chain with brand-name urban clothing.
Lakhany said this strategy should spark
the interest of shoppers. “People see it
and say, ‘Wait, what’s that?’” he said.
The line also has spread to small
independent stores in Adanta, adding a
grassroots touch, Lakhany said. He is
hoping his line will be sold in Belk’s by
this fall and in Dillard’s and Nordstrom
department stores later.
Lakhany said Dap-Rugget has gained
popularity via celebrity promotions.
Former Tribe Called Quest rapper Phife
Dawg gave thanks to Dap-Rugget on his
newest album, and rappe r Ludicris is
now on tour sporting the Jine. Outkast
and some Carolina Panthers can be
seen wearing Dap-Rugget in XXL, a
hip-hop lifestyle magazine.
Lakhany said Dap-Rugget’s theme
is recurring in everyday life, heighten
ing the line’s popularity. “A lot of
things in life are dap-rugget,” he said.
“You go to work at an office, you’re
dap. But then you go home, kick it
with your friends, you’re nugget.”
He said this is the reason celebrities
are willing to work with the brand.
“They say we’re the next HiJfiger,” he
said. “It’s really good to hear that kind
of feedback from people who know
what they’re talking about.”
But Lakhany also gets positive feed
back from friends. Dap-Rugget sup
porter Ron Lovelace said Lakhany’s
experience in the clothing industry
and his business know-how will take
him far. “Because of the hard work
he’s put in, the company has a lot of
upside potential, and I think it can do
really well,” he said.
Clothes labeled “Dap-Rugget” are
priced relative to brands like Polo at
S4O-60 a shirt. But Lakhany said the
value of his brand is incomparable.
“We’re selling the lifestyle more
than anything.”
The Features Editor can be reached
at features@unc.edu.
DISCUSSION
From Page 3
emony will hopefully bring a “renewed
interest” in the BCC.
The BCC, currently located in the
Student Union, will move to a three
story, 36,000-square-foot building located
between the Bell Tower and Coker Hall.
Amana said the goal of the week’s
events will “educate people about the
history of the BCC.” The week includes
educational video viewings, a BCC
Ambassadors Cultural Extravaganza
and the groundbreaking ceremony.
Amana said the BCC will reach out
to include the entire campus in its cele
bration. “Whenever students want to
use the center as a resource, we are in
support of that”
The University Editor can be reached
at udesk@unc.edu.